FDAnews Drug Daily Bulletin

Medivir Hep C Drug Cures 80 Percent of Patients Post-Treatment

April 20, 2012
A A
Medivir’s experimental hepatitis C treatment TMC435 cured as many as 80 percent of patients 24 weeks after treatment ended, suggesting that the therapy prevents the virus from surging back.
Bloomberg